Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




TAVI Procedure Supported by Radial Artery Access Reduces Bleeding Complications

By HospiMedica International staff writers
Posted on 22 Oct 2024

The TAVI procedure, or Transcatheter Aortic Valve Implantation, is a minimally invasive technique in which a new aortic valve is inserted through a femoral artery to replace a narrowed old valve. More...

This method is gaining popularity, particularly among individuals aged 75-80 and those with medical risks, as it is often favored over open-heart surgery, which presents greater risks and necessitates a longer recovery period. In TAVI procedures, two femoral arteries are employed: one for introducing the aortic valve and guiding it to the correct position, and the other for injecting contrast fluid, which enhances visualization of the aorta and ensures precise valve placement. While access through the wrist has become standard practice in procedures like angioplasty to reduce the risk of severe bleeding, this approach has not yet been adopted for TAVI. Now, new research indicates that part of the TAVI procedure can be performed via the radial artery instead of the femoral artery, leading to fewer bleeding complications.

In a randomized study conducted in collaboration with multiple centers, a team of cardiologists and researchers from Radboud University Medical Center (Nijmegen, Netherlands) explored whether this technique, already established in angioplasty procedures, could also benefit the TAVI procedure involving aortic valve replacement. Patients scheduled for TAVI participated in the study and were randomly assigned to one of two groups: the standard procedure using both femoral arteries or the new method where the heart valve was introduced via the femoral artery and the contrast fluid was administered through the radial artery. A total of 238 patients took part in the study, and the findings revealed that serious bleeding requiring medical intervention occurred almost exclusively in the femoral artery group.

Additionally, the researchers made another adjustment to the procedure. During TAVI, patients typically receive a temporary pacemaker because the new valve may cause cardiac arrhythmia. While this pacemaker is usually removed immediately after the procedure, it may occasionally remain in place for several days. Traditionally, a femoral vein is used for pacemaker insertion, but in patients who had contrast fluid delivered via the wrist, the pacemaker was instead inserted through an upper-arm vein. This research, published in JAMA Network Open, highlights the advantages of using the radial artery for administering contrast fluid, as it results in fewer bleeding complications. Although this method may take slightly longer than using only femoral arteries, the team anticipates that this approach will be increasingly integrated into practice.

“This is already common in angioplasty, and we have now shown that it also provides advantages in the TAVI procedure,” said Niels van Royen, last author and professor of Cardiology. “We have been performing TAVI procedures for about fifteen years, with promising results. New aortic valves seem to function just as well after ten years as standard surgical valves. If we can reduce the risks associated with the procedure, that would be a significant step forward.”

Related Links:
Radboud University Medical Center


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.